Skip to main content
. Author manuscript; available in PMC: 2023 Feb 16.
Published in final edited form as: Urol Oncol. 2021 Jun 19;40(2):56.e1–56.e8. doi: 10.1016/j.urolonc.2021.04.035

Table 3.

Association between pelvic radiation and general health-related patient-reported functional outcomes.

Time N Pelvic Radiation, median (quartiles) No Pelvic Radiation, median (quartiles) Combined, median (quartiles) Crude P-valuea Multivariable adjusted modelb
Pelvic Radiation vs. No Pelvic Radiation
Effect estimate (95% CI) P-value
SF36 physical functioning score
Baseline 564 85 (50, 95) 90 (70, 100) 90 (65, 100) 0.04 n/a
6 month 572 75 (45, 94) 85 (65, 95) 85 (60, 95) 0.003 2.44 (−2.31 to 7.18) 0.31
1 year 550 85 (50, 95) 90 (67, 100) 87 (65, 100) 0.003 2.03 (−2.49 to 6.54) 0.38
3 year 470 75 (45, 90) 85 (60, 95) 85 (55, 95) 0.003 −0.43 (−6.15 to 5.29) 0.88
5 year 415 70 (32, 95) 85 (60, 95) 85 (55, 95) 0.006 −3.74 (−10.92 to 3.43) 0.31
SF36 emotional well being score
Baseline 574 84 (68, 92) 88 (72, 92) 84 (72, 92) 0.76 n/a
6 month 571 84 (75, 92) 84 (71, 92) 84 (72, 92) 0.61 3.01 (0.19 to 5.83) 0.04
1 year 548 84 (68, 92) 84 (72, 92) 84 (72, 92) 0.90 2.30 (−0.31 to 4.91) 0.08
3 year 467 84 (76, 92) 88 (72, 92) 88 (72, 92) 0.71 1.40 (−2.19 to 4.99) 0.44
5 year 414 88 (72, 92) 88 (72, 92) 88 (72, 92) 0.90 2.48 (−1.40 to 6.36) 0.21
SF36 energy and fatigue score
Baseline 574 70 (55, 85) 75 (55, 85) 75 (55, 85) 0.50 n/a
6 month 571 65 (50, 80) 70 (50, 80) 70 (50, 80) 0.25 2.23 (−1.71 to 6.17) 0.27
1 year 548 65 (53, 75) 70 (50, 80) 70 (50, 80) 0.31 1.85 (−1.42 to 5.11) 0.27
3 year 467 70 (55, 80) 70 (55, 80) 70 (55, 80) 0.28 1.80 (−2.11 to 5.70) 0.37
5 year 414 65 (52, 80) 70 (50, 80) 70 (50, 80) 0.48 3.28 (−1.40 to 7.96) 0.17
a

Crude P-values are calculated by Wilcoxon test.

b

All regression models are adjusted for baseline domain score, time since treatment, biopsy Gleason score, PSA at diagnosis (corrected) and propensity scores.